retatrutide type 2 diabetes trial results 2024 2025 Results: 28.3% Weight Loss Data 🚨Breaking: Retatrutide's first Phase 3

Blood SIRT1 shows a coherent association with leptin and adiponectin in relation to the degree and distribution of adiposity: a study in obesity, normal weight and Anorexia Nervosa

Safety assessments conducted in clinical trials provide valuable insights into AEs within a specified population

Appetite effects: Act on brain regions controlling hunger and fullness Reduce appetite between meals Enhance feelings of satisfaction after eating Decrease food preoccupation and cravings Gastric effects: Slow stomach emptying Prolong feelings of fullness Reduce the volume of food needed to feel satisfied Metabolic effects: Improve insulin secretion (glucose-dependent) Reduce glucagon release Improve insulin sensitivity Both Saxenda and Ozempic work through these mechanisms

elife 4:e10832

Positive results - such as improved weight loss and metabolic health - can be highly motivating